News & Research

New studies, trials, regulatory changes and news about the compounds on Amino Reference. Items are collected automatically once a day and summarised by AI; they are not reviewed by an editor before they appear here. Read the original source before relying on anything.

Last updated 2026-10-05.

• TrialCagrilintideGLP1-SGLP1-S / Cagrilintide blend2026-09-30
  A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight (recruiting)

  ClinicalTrials.gov

  A trial is recruiting children and adolescents with excess body weight to test cagrilintide and CagriSema. The site should say these products are not established for minors and that this is a pharmaceutical trial, not a reason to use research material in children.

• TrialSurvodutide2026-10-01
  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis (recruiting)

  ClinicalTrials.gov

  The LIVERAGE trial of survodutide in MASH with moderate or advanced fibrosis is recruiting. Readers should see this as ongoing human research, not as evidence that survodutide treats liver fibrosis.

• TrialSurvodutide2026-10-01
  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis (recruiting)

  ClinicalTrials.gov

  A companion LIVERAGE trial of survodutide in MASH with cirrhosis is recruiting. The page should separate this higher-risk ongoing study from any claim of benefit in advanced liver disease.

• TrialSurvodutide2026-09-30
  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) (completed)

  ClinicalTrials.gov

  The survodutide cardiovascular outcomes trial, SYNCHRONIZE-CVOT, is listed as completed. This registry update does not include results, so no cardiovascular benefit or harm should be claimed from the status change alone.

• TrialSurvodutide2026-10-02
  SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (not yet recruiting)

  ClinicalTrials.gov

  SYNCHRONIZE-START, a survodutide weight-loss trial in people with overweight or obesity without diabetes, is listed as not yet recruiting. The page should not describe that non-diabetes phase 3 study as enrolled or completed.